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Cystic lesions of the pancreas are a rare entity, and few reports have described their natural history in
children. A previously published report described a 9-year-old boy with an acinar cell cystadenoma,
discovered during a laparoscopic appendectomy. Initially asymptomatic and followed by serial MRI, this
patient presented to our institution several years later with chronic obstructive symptoms that required
surgical intervention. Planning for resection included multidisciplinary input from the genetics and
endocrinology services. Initially, a partial pancreatic resection was performed in an attempt to preserve
normal pancreatic tissue and islet cell function. Progression of the cystic disease and recurrent
obstruction necessitated further surgical intervention. Here we present the updated clinical course and
outcome of a 12-year-old boy who underwent a total pancreaticoduodenectomy for a symptomatic
acinar cell cystadenoma.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A 9-year-old boy was found to have a large pancreatic mass of 5.6%. Our patient was evaluated by the pediatric genetics team for
during a routine laparoscopic appendectomy and was referred to a
tertiary-care center. In a previously described report, the patient
underwent a laparoscopic incisional biopsy and was diagnosed
with a pancreatic acinar cell cystadenoma (PAC) [1]. The lesion was
followed with serial MRIs, and the cystic portion of the pancreas
was stable and asymptomatic.
Eighteen months later the patient developed symptoms of early
satiety, weight loss, and epigastric painwhich were interfering with
his school and social activities. He visited several tertiary-care
centers in multiple states, exploring the possibility of resection and
pancreas transplantation. He presented to our institution with
intermittent obstruction due to extrinsic duodenal compression,
and was dependent on total parenteral nutrition (TPN). In March of
2010, the patient underwent evaluation for partial pancreatic
resection to relieve his obstructive symptoms.1. Clinical course
The patient was hemodynamically normal upon presentation,
with a weight of 39.4 kg. He was somewhat gaunt in appearance,
with a PICC line in place, a serum albumin of 4.3 g/dL, and an HgA1cvel, Bronx, NY 10467, USA.
onteﬁore.org (D.G. Darcy).
Inc. This is an open access article ua possible diagnosis of von Hippel-Lindau (VHL) disease. This auto-
somaldominantdisease is rare;however, it canmanifestwith simple
cysts, and serous cystadenomas of the pancreas. While approxi-
mately 3 out of 4 patients with VHL will have pancreatic cysts, they
have not been reported to cause extrinsic compression and gastro-
intestinal obstruction. Our patient did not have any genetic
mutations that have been associated with VHL. The pediatric
endocrinology servicewas consulted for perioperativemanagement
of insulin while planning for a partial pancreaticoduodenectomy.
During exploratory laparotomy in April 2010, the entire body
and tail of the pancreas were grossly composed of cystic structures;
however, the head and uncinate process were composed of normal-
appearing tissue. The head and uncinate process derive from a
distinct ventral bud during pancreatic development, and consid-
ering that they might have been spared from cystic progression,
they were preserved. A distal pancreatectomy was performed, and
the omentum having been resected, a loop gastrojejunostomy was
created to improve gastric emptying. The patient resumed enteral
feeding and was discharged without need for TPN. On pathology
review, the surgical specimen was consistent with his prior diag-
nosis of PAC (Fig. 1). In June 2010, the patient returned with
bilious vomiting. Upper gastrointestinal series showed a patent
duodenum with a partially-obstructed gastrojejunostomy. The
gastrojejunostomy was reversed, and normal bowel continuity
having been restored, the patient was discharged on regular diet.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Hematoxylin and eosin stained slide showing diffuse involvement of the pa-
renchyma by variably sized cystic spaces containing crystalized, eosinophilic enzymatic
secretions. Lining cells are cuboidal, with minimal cytoplasm and lack atypia.
Fig. 3. Gross pathology specimen from completion pancreaticoduodenectomy showing
cystic replacement of the entire remnant pancreas.
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returned in May of 2012 with weight loss, early satiety, and
epigastric pain. Abdominal MRI demonstrated progressive cystic
disease of the head and uncinate process of the pancreas (Fig. 2).
After multidisciplinary discussion, the patient was taken back to the
operating room in July 2012, where a pylorus-sparing pan-
creaticoduodenectomy was performed. The resected specimen
contained virtually no normal pancreatic tissue, and had no
evidence of malignant transformation (Fig. 3).
An insulin pump and oral pancreatic enzyme replacement were
initiated. The patient has subsequently done well, followed in the
last two years by our hospital. He maintains a normal diet with 3
meals a day plus snacks before exercise, with bolus insulin coverage
for meals. His HgA1c is 5.9%, and his pump is managed by the
patient’s parents in concert with pediatric endrocrinology every
three months. He takes pancreatic enzyme replacement with meals
and he does not suffer from steatorrhea. He is doing well in school,
and has begun playing baseball, with attention to avoid hypogly-
cemic episodes and with glucagon on hand at practice. His weight
has steadily improved, 47 to 50 to 53 kg at his most recent clinic
visits, and is in the 45th percentile.
2. Discussion
Our patient was presented previously as the youngest published
case of PAC, and was initially managed conservatively with serialFig. 2. Maximum Intensity Projection MRI image showing cystic replacement of the
head and uncinate process of the pancreas, status post distal pancreatectomy.MRI. Our patient already had a biopsy-conﬁrmed diagnosis, and
normal HgA1c denoting functioning islet cells; the decision to
intervene surgically was methodically investigated and carefully
planned using a multidisciplinary approach. During his initial
surgery for duodenal obstruction, the uncinate process and head
of the pancreas appeared normal and they were not resected,
with the hope of preserving pancreatic function. Subsequent pro-
gression of cystic disease, duodenal obstruction, TPN dependence,
and weight loss ultimately necessitated a completion pan-
creaticoduodenectomy. A pylorus-sparing resection was performed
because the indication was not malignancy, and for the possible
beneﬁts of intact gastric physiology with less dumping syndrome in
the setting of diabetes. Outcomes of pylorus-sparing versus a classic
pancreaticoduodenectomy are mixed in adult patients, however, in
pediatric patients there is no clinical data and cases are rare. This
case represents the stepwise management and considerations for
PAC in an adolescent male.
Pancreatic acinar cystic lesions of the pancreas were ﬁrst
described as a rare cystic neoplasm by Albores-Saavedra in 2002
[2]. PAC are found mostly in middle-aged adults (mean age at
diagnosis of 47-years-old), and they can be discrete or encom-
passing the entire gland [2e4]. Most series have an overwhelming
predominance of female patients, however, our patient and occur-
rence in other male patients have been reported (REF Singhi 7/8,
Zamboni 7/10). In a review of 10 cases, themost common indication
for surgery was pain with ﬁndings of cystic neoplasm on CT scan;
the other 4 had PAC found incidentally upon resection for other
tumors [4]. PAC can be distinguished from branch-duct intraductal
papillary mucinous neoplasms (IPMN) with high sensitivity and
speciﬁcity based on four radiological criteria (CT or MRI) [5]. H&E
analysis of our patient’s pathology lacked mitoses, and the acinar
cells lining the cysts lacked atypia. Affected cells can be differen-
tiated from normal acinar cells by staining positive for CK7 [6],
however, this was not performed on our specimen.
The origin of PAC has not been fully elucidated. Albores-Saave-
dra noted cysts lined with duct-like cells representing metaplastic
change [2]. Chatelain considered it to be a cystic variant of acinar
cell adenomas, unrelated to normal pancreatic acini [7]. In oppo-
sition, Gumus found cysts continuous with normal pancreatic acini,
without discrete lesions; therefore, they suggested the description
“acinar cystic transformation [8].” Albores-Saavedra noted ﬁbrosis
of surrounding pancreatic tissue, while Zamboni noted discrete
lesions without histopathologic changes in the adjacent tissue [4].
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ﬁndings of Chatelain, with a diseased pancreatic body and tail, and
a normal appearing head and uncinate process. Ultimately, his
disease was progressed to diffuse involvement, consistent with the
description by Gumus, with almost complete replacement of
normal tissue. Had we suspected it would progress, we would have
done a complete resection and spared the patient two additional
surgeries.
More recently genetic investigations by Khor et al. using array
comparative genomic hybridization found copy number variations
across 11 different chromosomes, suggesting a neoplastic process
[9]. However, Singhi et al. found random chromosome X inactiva-
tion in 5 of 7 samples, denoting a polyclonal population without
evidence of a neoplastic genome [10]. Genetic testing ruled out VHL
syndrome in our patient, however, that diagnosis was seriously
considered as it can have cystic disease of the pancreas including
serous cystadenomas and neuroendocrine tumors.
3. Conclusion
While there are no published cases of PAC with malignant
transformation necessitating resection, this case demonstrates a
role for surgical management due to progressive cystic change and
extrinsic compression. This patient was appropriately diagnosed
and managed using minimally invasive techniques, and followed
closely with MRI surveillance, with which we completely agree [1].
However, progression of our patient’s PAC to encompass the entire
gland necessitated complete pancreaticoduodenectomy, leaving
him dependent on replacement enzymes and an insulin pump.
Continued development of therapeutic modalities such as pancre-
atic islet transplant could offer intrinsic replacement for this
patient; currently he is followed closely by pediatric endocrinology,
takes daily pancreatic enzyme replacement, and has a normal social
life using an insulin pump. Fortunately, this rare lesion can be
distinguished from VHL and IPMN through genetic testing and
CT/MRI imaging. Ultimately, treatment should be based on symp-
toms, with serial MRI imaging for a stable lesion, and multidisci-plinary planning should surgical intervention become necessary.
Total pancreaticoduodenectomy was the ﬁnal treatment in our
patient, although whole pancreas or islet transplant are available if
necessary in the future.
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